Fusionex and IMU Introduce Big Data Analytics to Accelerate Medical Education and Research



Multi-award winning data technology provider, Fusionex, and Malaysia’s pioneering private medical and health science university, International Medical University (IMU), are taking a bold step to integrate big data analytics (BDA) and artificial intelligence (AI) in the Medicine and Health Sciences programs at IMU. To equip future healthcare providers with the right set of skills and knowledge, this collaboration will see five IMU undergraduate programs each pilot a BDA module.

The five programs are Bachelor of Pharmacy (Hons), BSc (Hons) in Medical Biotechnology, BSc (Hons) in Dietetics with Nutrition, BSc (Hons) in Nutrition and BSc (Hons) in Biomedical Sciences. These will be some of the first non-ICT degree programs to incorporate BDA as part of their curriculum.

In order to meet the future technological needs of the industry, Fusionex will use its AI and BDA platform, Fusionex GIANT, which will be integrated into the programs offered by the IMU.

These programs will provide four outcomes: an overview of the analytics lifecycle, how analytics contributes to the healthcare industry, why data-driven decision-making is essential for an organization, and the effective use of analytical skills. and AI to solve health-related problems.

Fusionex and IMU have also expressed their commitment to integrate the fields of technology and medicine with the exchange of a Memorandum of Understanding (MoA). The MoA was exchanged by IMU Deputy Vice-Chancellor Professor Peter Pook and Fusionex Group Founder and CEO Dato’ Seri Ivan Teh during the Healthcare Big Data Analytics Forum.

The forum was held at the IMU campus and was jointly organized by IMU, the Malaysia Digital Economy Corporation (MDEC) and Fusionex.

The MoA sees both parties leveraging their respective strengths – Fusionex using BDA and AI, and IMU bringing its expertise and knowledge in the healthcare sector – to work together on various aspects of medical research and development (R&D) , including cancer informatics, advanced drugs, vaccine design, and healthcare analytics.

In order to build a self-learning AI project, the program must be fed with billions of data points. Only with such extensive training can an AI begin to visualize, diagnose, test, and predict medical outcomes intelligently, quickly, and accurately.

To achieve this, the GIANT platform connects to IMU data points, consolidates and analyzes the data through its artificial intelligence technology to discover patterns and trends, and generate valuable insights that the team of the IMU R&D can use. This knowledge offers benefits whose value cannot be quantified, including reducing diagnosis and treatment times for patients and achieving breakthroughs in medical research, ultimately saving lives. Even unstructured data outside of academia, including new drugs on the market and their effects, or new findings and announcements from the Ministry of Health or the World Health Organization, can be compiled and introduced in the AI ​​engine as part of IMU’s R&D efforts.

As part of the partnership under the MoA, IMU research teams will also be equipped with knowledge on BDA and AI, particularly on how to most effectively use GIANT, including finding patterns in the data and the analysis of information derived from that data. Fusionex trainers, data scientists and subject matter experts will be on hand to educate and help IMU manage the technology provided to achieve BDA and AI readiness.

Dato’ Seri Ivan Teh, Founder of Fusionex and Group CEO, said, “We are delighted to be pioneering this AI-based medical research initiative with IMU. Their foresight in transforming their medical education and research to become data-ready and AI-driven is commendable. The Fusionex team will work to improve medical education and research to advance the medical industry and healthcare as a whole.

“IMU has always aimed to be an innovative global center of excellence in learning and research, which is why we are always ready to team up with experts in the field of technology – especially in Big Data Analytics (BDA) and Artificial Intelligence (AI) – like Fusionex This is the direction in which healthcare is headed, and it is of the utmost importance for the IMU to prepare for the future of our students in this field so that they are fully equipped to face the future of healthcare after graduation. I am excited to see where this collaboration with Fusionex will take us and how it can be extended to other areas. ‘other programs in the future for the benefit of our students,’ said Professor Abdul Aziz Baba, Vice Chancellor and CEO of IMU.

About Fusionex

Fusionex is a recognized and multi-award winning data technology provider specializing in Analytics, Big Data, IR 4.0, Machine Learning and Artificial Intelligence. Its offerings aim to help customers unlock value and learn from data. Featured on Forbes, Bloomberg, Gartner, IDC, Forrester, Edison, and Huffington Post, Fusionex is ASEAN’s largest big data analytics company and market leader, delivering industry-leading, innovative, and game-changing platforms focused on data to its stable customer base (including Fortune 500, FTSE companies, large conglomerates as well as a wide range of small and medium enterprises (SMEs)) which spans the United States, Europe as well as Asia -Peaceful. Fusionex is also an MDEC GAIN company as well as an MGS recipient.

Gartner’s 2018 Modern Analytics and Business Intelligence Report shortlisted and commended Fusionex’s data technology platform. Additionally, Fusionex has been identified as a major player in IDC’s MarketScape report for Big Data and Analytics. Fusionex is the only ASEAN-based company to feature in both reports, bolstering its credentials in the data technology market for this region.

To learn more about Fusionex, visit fusionexnews.com.

Contact information

Company: AsianChannel
Name: Rebecca Goh
Email: [email protected]
Address: Kuala Lumpur, MY

Source link


Comments are closed.